Assenagon Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Buy |
16,610
+1,394
| +9% | +$32K | ﹤0.01% | 1046 |
|
|
2025
Q1 | $441K | Sell |
15,216
-146,183
| -91% | -$4.24M | ﹤0.01% | 1017 |
|
|
2024
Q4 | $5.99M | Sell |
161,399
-5,956
| -4% | -$221K | 0.01% | 624 |
|
|
2024
Q3 | $8.12M | Sell |
167,355
-22,250
| -12% | -$1.08M | 0.01% | 559 |
|
|
2024
Q2 | $7.58M | Buy |
189,605
+35,306
| +23% | +$1.41M | 0.02% | 481 |
|
|
2024
Q1 | $6.78M | Buy |
+154,299
| New | +$6.78M | 0.02% | 501 |
|
|
2023
Q3 | – | Sell |
-12,123
| Closed | -$697K | – | 1334 |
|
|
2023
Q2 | $697K | Sell |
12,123
-156,933
| -93% | -$9.02M | ﹤0.01% | 1019 |
|
|
2023
Q1 | $6.34M | Sell |
169,056
-4,423
| -3% | -$166K | 0.02% | 486 |
|
|
2022
Q4 | $4.86M | Buy |
173,479
+28,263
| +19% | +$792K | 0.02% | 508 |
|
|
2022
Q3 | $4.08M | Sell |
145,216
-273,801
| -65% | -$7.69M | 0.02% | 513 |
|
|
2022
Q2 | $14.6M | Sell |
419,017
-8,588
| -2% | -$299K | 0.05% | 267 |
|
|
2022
Q1 | $15.4M | Sell |
427,605
-100,073
| -19% | -$3.59M | 0.04% | 256 |
|
|
2021
Q4 | $12.3M | Buy |
527,678
+349,875
| +197% | +$8.15M | 0.04% | 256 |
|
|
2021
Q3 | $3.38M | Sell |
177,803
-12,214
| -6% | -$232K | 0.01% | 498 |
|
|
2021
Q2 | $3.83M | Buy |
190,017
+29,770
| +19% | +$600K | 0.01% | 509 |
|
|
2021
Q1 | $2.94M | Buy |
+160,247
| New | +$2.94M | 0.01% | 596 |
|
|
2019
Q1 | – | Sell |
-65,926
| Closed | -$1.31M | – | 891 |
|
|
2018
Q4 | $1.31M | Buy |
+65,926
| New | +$1.31M | 0.01% | 540 |
|